Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 3 (1), 1-2

Bedaquiline: First FDA-approved Tuberculosis Drug in 40 Years

Affiliations

Bedaquiline: First FDA-approved Tuberculosis Drug in 40 Years

Rajiv Mahajan. Int J Appl Basic Med Res.

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

See all similar articles

Cited by 34 articles

See all "Cited by" articles

References

    1. Walker J, Tadena N. J and J tuberculosis drug gets fast-track clearance. The Wall Street Journal. 2013. Jan 02, [Last cited on 2013 Mar 17]. Available from: http://online.wsj.com/article/SB10001424127887323320404578213421059138236.html .
    1. Matteelli A, Carvalho AC, Dooley KE, Kritski A. TMC207: The first compound of a new class of potent anti-tuberculosis drugs. Future Microbiol. 2010;5:849–58. - PMC - PubMed
    1. Thomas K. FDA approves drug for resistant tuberculosis. [Last cited on 2013 Mar 18]. Available from: http://www.nytimes .com/2013/01/01/business/fda.approves.new.tuberculosis.drug.html?_r=2. and .
    1. US Food and Drug Administration. FDA news release. [Last cited on 2013 Mar 18]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm .
Feedback